This highlights the need for further research to establish the safety and efficacy of semaglutide in patients with a history of psychiatric conditions
When engaged together, these interactions reveal complex synergistic or opposing effects across tissues like the liver, pancreas, adipose tissue, and brain
Key takeaways Wegovy is a glucagon-like peptide-1 (GLP-1) agonist available in a weekly injection or daily tablet
Market Opportunity : Major opportunities include oral GLP-1 innovations, combination therapies integrating GIP/GLP-1 pathways, improved affordability for emerging markets, expanding indications beyond diabetes and obesity, and partnerships to enhance manufacturing capacity, distribution, and long-term patient adherence
Get these numbers wrong and you are either wasting expensive peptide or taking doses wildly different from what clinical trials actually studied
Amongst people living with the HF with preserved ejection fraction phenotype (HFpEF